PaulEdwardGossMDMBBCh, Ph.D.
Hematology • Boston, MAHematologic Oncology
Director of Breast Cancer Research, Massachusetts General Hospital; Co-Director, Breast Cancer Disease Program, Dana-Farber/Harvard Cancer Center (DF/HCC)
Are you Dr. Goss?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 21 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
55 Fruit St
Cox Building Ste 640
Boston, MA 02114Phone+1 617-724-3118Fax+1 617-724-3166- Is this information wrong?
Summary
- Dr. Paul Goss, MD is a hematologist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts. He is a Director of Breast Cancer Research at Breast Cancer Disease Program.
Education & Training
University of the WitwatersrandClass of 1978
Certifications & Licensure
MA State Medical License 2004 - 2021
Clinical Trials
- Letrozole After Tamoxifen in Treating Women With Breast Cancer Start of enrollment: 1998 Aug 24
- Exemestane or Anastrozole in Treating Postmenopausal Women Who Have Undergone Surgery for Primary Breast Cancer Start of enrollment: 2003 Jun 06
- Exemestane in Reducing Breast Density in Postmenopausal Women at Risk for Breast Cancer Start of enrollment: 2001 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- Predicting the clinical outcomes and benefit from letrozole after 5 years of treatment with aromatase inhibitors for early breast cancer: analysis from CCTG MA.17RYapeng Li, Xueying Zheng, Dongsheng Tu, James N. Ingle, Paul E. Goss, Wendy R. Parulekar, Guoyou Qin> ;Breast Cancer Research and Treatment. 2021 Nov 26
- 13 citationsPostpartum breast cancer has a distinct molecular profile that predicts poor outcomes.Sonali Jindal, Nathan D. Pennock, Duanchen Sun, Wesley Horton, Michelle K. Ozaki, Jayasri Narasimhan, Alexandra Q. Bartlett, Sheila Weinmann, Paul E. Goss, Virginia F....> ;Nature Communications. 2021 Nov 3
- 4 citationsInteraction Between SNP Genotype and Efficacy of Anastrozole and Exemestane in Early-Stage Breast Cancer.Junmei Cairns, Krishna R. Kalari, James N. Ingle, Lois E. Shepherd, Matthew J. Ellis, Paul E. Goss, Poulami Barman, Erin E. Carlson, Barbara Goodnature, Matthew P. Goe...> ;Clinical Pharmacology and Therapeutics. 2021 Oct 1
- Join now to see all
Press Mentions
Breast Cancer Symptoms: What Are the Early Signs You Should Look Out For?December 21st, 2022- New GCI Study on Gynecologic Cancers in Brazil Finds Most Patients Present with Advanced DiseaseJanuary 20th, 2021
Best Oncologists in BrisbaneJune 9th, 2019- Join now to see all
Professional Memberships
- Member
